A. Silicosis The major concern is silicosis (lung disease), caused by the inhalation and retention of respirable crystalline silica dust. Silicosis can exist in several form, chronic (or ordinary), accelerated, or acute. Chronic or Ordinary Silicosis is the most common form of silicosis, and can occur after many years of exposure to levels above the occupational exposure limits for airborne respirable crystalline silica dust. It is further defined as either simple or complicated silicosis. Simple silicosis is characterized by lung lesions (shown as radiographic opacities) less than 1 centimeter in diameter, primarily in the upper lung zones. Often, simple silicosis is not associated with symptoms, detectable changes in lung function or disability. Simple silicosis may be progressive and may develop into complicated silicosis or progressive massive fibrosis (PMF). Complicated silicosis or PMF is characterized by lung lesions (shown as radiographic opacities) greater than 1 centimeter in diameter. Although there may be no symptoms associated with complicated silicosis or PMF, the symptoms, if present, are shortness of breath, wheezing, cough and sputum production. Complicated silicosis or PMF may be associated with decreased lung function and may be disabling. Advanced complicated silicosis or PMF may lead to death. Advanced complicated silicosis or PMF can result in heart disease secondary to the lung disease (corpumonale). Accelerated Silicosis can occur with exposure to high concentrations of respirable crystalline silica over a relatively short period; the lung lesions can appear within five (5) years of the initial exposure. The progression can be rapid. Accelerated silicosis is similar to chronic or ordinary silicosis, except that the lung lesions appear earlier and the progression is more rapid. Acute Silicosis can occur with exposures to very high concentrations of respirable crystalline silica over a very short time period, sometimes as short as a few months. The symptoms of acute silicosis include progressive shortness of breath, fever, cough and weight loss. Acute silicosis is fatal. B. CANCER IARC - The International Agency for Research on Cancer ("IARC") concluded that there was "sufficient evidence in humans for the carcinogenicity of crystalline silica in the forms of quartz or cristbolite from occupational sources", and that there is "sufficient evidence in experimental animals for the carcinogenicity of quartz and cristobalite." The overall IARC evaluation was that "crystalline silica inhaled in the form of quartz or cristobalite from occupational sources is carcinogenic to humans (Group 1)." The IARC evaluation noted that "carcinogenicity was not detected in all industrial circumstances studies. Carcinogenicity may be dependent on inherent characteristics of the crystalline silica or on external factors affecting its biological activity or distribution of its polymorphs." For further information on the IARC evaluation, see IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 68, "Silica, Some Silicates..." (1997). NTP - The National Toxicology Program, in its Sixth Annual Report on Carcinogens, concluded that "silica, crystalline (respirable)" may reasonably be anticipated to be a carcinogen, based on sufficient evidence in experimental animals and limited evidence in humans. There is substantial literature on the issues of the carcinogenicity of crystalline silica, which the reader should consult for additional information. A summary of the literature is set forth in "Exposure to crystalline silica and risk of lung cancer; the epidemiological evidence", Thorax, Volume 51, pp. 97-102 (1996). The official statement of the American Thoracic Society of the issue of silica carcinogenicity was published in "Adverse Effects of Crystalline Silica Exposure", Americna Journal of Respiratory and Critical Care Medicine, Volume 155, pp. 761-765 (1997). The official statement concluded that "The available data support the conclusion that silicosis produces increased risk for bronchogenic carcinoma. The cancer risk may also be increase by smoking and other carcinogens in the workplace. Epidemiologic studies provide convincing evidence for increased caner risk among tobacco smokers with silicosis. Less information is available for never-smokers and for workers exposed to silica but who do not have silicosis. For workers with silicosis, the risks for lung cancer are relatively high and consistent among various countries and investigators. Silicosis should be considered a condition a condition that predisposes workers to an increased risk of lung cancer." ld. at 763. |